Overall rank by patents
#690
of 49,997 tracked assignees
USPTO PatentsView assignee record - 654 granted patents across 111 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).
The verdict
According to USPTO PatentsView, Roche ranks #690 of 49,997 tracked US assignees by granted-patent volume, with 654 patents across 111 technology areas.
USPTO PatentsView assignee plate
Corpus R690 · US Corporation #690 · 654 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL
Nearest grant-volume peer: pSemi Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Global Graphene Group · near
62 score
NGK Insulators · near
62 score
WM Intellectual… · near
62 score
Roche Diagnostics… · this assignee
62 score
Ramot at Tel-Aviv… · near
62 score
3D Lighting… · lowest
7 score
What this shows Roche's Innovation Score is 62.0/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Between 2020–2024, Roche Diagnostics Operations, Inc. received 280 grants versus 331 in 2015–2019 (-15% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2015 at 101 grants and bottomed in 2020 at 39. Lead class G01N accounts for 73.7% of the portfolio across 111 subclasses. Volume neighbours: Inventec Corporation (#685) and Incyte Corporation (#693).
From 2019–2021 to 2022–2024, Roche Diagnostics Operations, Inc. moved from 179 to 176 grants (0.98x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,226. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Inventec Corporation
656 patents
Immersion, LLC
656 patents
American Express Travel Related Services Company, Inc.
655 patents
TS Tech Co., Ltd.
655 patents
pSemi Corporation
654 patents
Roche Diagnostics Operations, Inc.
654 patents
Nederlandse Organisatie voor toegepast-natuurwetenschappelijk onderzoek TNO
653 patents
Hughes Network Systems, LLC
652 patents
Incyte Corporation
652 patents
What this shows Roche holds 654 patents at rank #689, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #689 in granted patent volume.
Other assignees with the most granted patents in Roche's primary technology class.
Two PlainPatent-derived peer sets for Roche, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (62 here).
Nearest assignees by average claims per patent (13.5 here).
Roche's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
62 Top 3% higher than 97% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 101 | 15.4% |
| 2016 | 48 | 7.3% |
| 2017 | 49 | 7.5% |
| 2018 | 58 | 8.9% |
| 2019 | 75 | 11.5% |
| 2020 | 39 | 6.0% |
| 2021 | 65 | 9.9% |
| 2022 | 55 | 8.4% |
| 2023 | 50 | 7.6% |
| 2024 | 71 | 10.9% |
| 2025partial year | 43 | 6.6% |
Top 15 of 111 technology areas
Overall rank by patents
#690
of 49,997 tracked assignees
62.0 out of 100
What to do with this data
Roche Diagnostics Operations, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.